Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy
- 1 January 2000
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 355 (9200), 253-259
- https://doi.org/10.1016/s0140-6736(99)12323-7
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Nephropathy in Patients with Type 2 Diabetes MellitusThe New England Journal of Medicine, 1999
- Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDMDiabetes Care, 1998
- The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and HypertensionThe New England Journal of Medicine, 1998
- Rationale and Design of a Large Study to Evaluate the Renal and Cardiovascular Effects of an ACE Inhibitor and Vitamin E in High-Risk Patients With Diabetes: The MICRO-HOPE StudyDiabetes Care, 1996
- Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registryThe American Journal of Cardiology, 1996
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyThe New England Journal of Medicine, 1993
- A Prospective Population-Based Study of Microalbuminuria as a Predictor of Mortality in NIDDMDiabetes Care, 1993
- Prevalence and causes of albuminuria in non-insulin-dependent diabetic patientsKidney International, 1992
- Eight to nine year mortality in known non-insulin dependent diabetics and controlsKidney International, 1992
- Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.BMJ, 1983